Tags

Type your tag names separated by a space and hit enter

Effectiveness of laparoscopic sleeve gastrectomy for weight loss and obesity-associated co-morbidities: a 3-year outcome from Mainland Chinese patients.
Surg Obes Relat Dis. 2016 Aug; 12(7):1305-1311.SO

Abstract

BACKGROUND

Laparoscopic sleeve gastrectomy (LSG) is becoming a stand-alone bariatric surgery for obesity, but its effectiveness for Mainland Chinese patients remains unclear.

OBJECTIVES

To evaluate the effectiveness and safety of LSG for Mainland Chinese patients SETTING: A tertiary hospital METHODS: Retrospective analysis of patients admitted for LSG between January 2011 and February 2012 was performed. Medium-term outcome measures were: total weight loss (%TWL), excess weight loss (%EWL), co-morbidities, improvement, and complications.

RESULTS

Seventy patients (body mass index [BMI] 40.8±5.9 kg/m2) underwent LSG, comprising 40 women and 30 men. The most common co-morbidity was diabetes (n = 29, 41.4%). Lost to follow-up rate for weight loss was 15.7%, 31.4%, and 41% at 1, 2, and 3 years. The %TWL was 34.4±6.1, 34.7±6.2 and 33.7±7.1 at 1, 2, and 3 years. The %EWL increased to 77.1±13.0, 77.9±12.2 and 77.2±13.1 at 1, 2, and 3years. The proportions of patients having successful weight loss were 100% or 85% at 3 years according the definition of %TWL>10% or %EWL>50%. Approximately 79.3%, 51.7%, and 44.8% of patients completed follow-up for glycemic control at each time point, respectively. The proportions of patients with optimal glycemic control (fasting blood glucose [FBG]<5.6 mmol/L; hemoglobin A1C [HbA1C]<6.5%) were 47.9%, 60.0%, and 69.2% at 1, 2, and 3years. The weight loss and glycemic control effect may be greater in the high BMI group (≥40 kg/m2). Early and late complications occurred in 8.6% and 7.1% of patients during follow-up.

CONCLUSIONS

LSG is effective in weight loss and glycemic control and is safe for Mainland Chinese obese patients, especially for patients with a BMI≥40 kg/m2.

Authors+Show Affiliations

Department of General Surgery, Changhai Hospital, The Second Military Medical University, Shanghai 200433, China; Department of Gynaecology and Obstetrics, The 306 Hospital of PLA, Beijing 100037, China.Department of General Surgery, Yancheng City First People's Hospital, Jiangsu 224000, China.Department of Pathology and Pathophysiology, Dalian Medical University, Liaoning 10008, China.Department of General Surgery, Changhai Hospital, The Second Military Medical University, Shanghai 200433, China.Department of General Surgery, Changhai Hospital, The Second Military Medical University, Shanghai 200433, China.Department of General Surgery, Changhai Hospital, The Second Military Medical University, Shanghai 200433, China.Department of General Surgery, Changhai Hospital, The Second Military Medical University, Shanghai 200433, China. Electronic address: guodhhdhf@163.com.

Pub Type(s)

Journal Article
Observational Study

Language

eng

PubMed ID

27297975

Citation

Wang, Xin, et al. "Effectiveness of Laparoscopic Sleeve Gastrectomy for Weight Loss and Obesity-associated Co-morbidities: a 3-year Outcome From Mainland Chinese Patients." Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery, vol. 12, no. 7, 2016, pp. 1305-1311.
Wang X, Chang XS, Gao L, et al. Effectiveness of laparoscopic sleeve gastrectomy for weight loss and obesity-associated co-morbidities: a 3-year outcome from Mainland Chinese patients. Surg Obes Relat Dis. 2016;12(7):1305-1311.
Wang, X., Chang, X. S., Gao, L., Zheng, C. Z., Zhao, X., Yin, K., & Fang, G. E. (2016). Effectiveness of laparoscopic sleeve gastrectomy for weight loss and obesity-associated co-morbidities: a 3-year outcome from Mainland Chinese patients. Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery, 12(7), 1305-1311. https://doi.org/10.1016/j.soard.2016.03.004
Wang X, et al. Effectiveness of Laparoscopic Sleeve Gastrectomy for Weight Loss and Obesity-associated Co-morbidities: a 3-year Outcome From Mainland Chinese Patients. Surg Obes Relat Dis. 2016;12(7):1305-1311. PubMed PMID: 27297975.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Effectiveness of laparoscopic sleeve gastrectomy for weight loss and obesity-associated co-morbidities: a 3-year outcome from Mainland Chinese patients. AU - Wang,Xin, AU - Chang,Xu-Sheng, AU - Gao,Lin, AU - Zheng,Cheng-Zhu, AU - Zhao,Xin, AU - Yin,Kai, AU - Fang,Guo-En, Y1 - 2016/03/08/ PY - 2015/10/14/received PY - 2016/02/29/revised PY - 2016/03/04/accepted PY - 2016/10/26/pubmed PY - 2017/10/24/medline PY - 2016/6/15/entrez KW - Mainland Chinese patients KW - laparoscopic sleeve gastrectomy KW - obesity SP - 1305 EP - 1311 JF - Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery JO - Surg Obes Relat Dis VL - 12 IS - 7 N2 - BACKGROUND: Laparoscopic sleeve gastrectomy (LSG) is becoming a stand-alone bariatric surgery for obesity, but its effectiveness for Mainland Chinese patients remains unclear. OBJECTIVES: To evaluate the effectiveness and safety of LSG for Mainland Chinese patients SETTING: A tertiary hospital METHODS: Retrospective analysis of patients admitted for LSG between January 2011 and February 2012 was performed. Medium-term outcome measures were: total weight loss (%TWL), excess weight loss (%EWL), co-morbidities, improvement, and complications. RESULTS: Seventy patients (body mass index [BMI] 40.8±5.9 kg/m2) underwent LSG, comprising 40 women and 30 men. The most common co-morbidity was diabetes (n = 29, 41.4%). Lost to follow-up rate for weight loss was 15.7%, 31.4%, and 41% at 1, 2, and 3 years. The %TWL was 34.4±6.1, 34.7±6.2 and 33.7±7.1 at 1, 2, and 3 years. The %EWL increased to 77.1±13.0, 77.9±12.2 and 77.2±13.1 at 1, 2, and 3years. The proportions of patients having successful weight loss were 100% or 85% at 3 years according the definition of %TWL>10% or %EWL>50%. Approximately 79.3%, 51.7%, and 44.8% of patients completed follow-up for glycemic control at each time point, respectively. The proportions of patients with optimal glycemic control (fasting blood glucose [FBG]<5.6 mmol/L; hemoglobin A1C [HbA1C]<6.5%) were 47.9%, 60.0%, and 69.2% at 1, 2, and 3years. The weight loss and glycemic control effect may be greater in the high BMI group (≥40 kg/m2). Early and late complications occurred in 8.6% and 7.1% of patients during follow-up. CONCLUSIONS: LSG is effective in weight loss and glycemic control and is safe for Mainland Chinese obese patients, especially for patients with a BMI≥40 kg/m2. SN - 1878-7533 UR - https://www.unboundmedicine.com/medline/citation/27297975/Effectiveness_of_laparoscopic_sleeve_gastrectomy_for_weight_loss_and_obesity_associated_co_morbidities:_a_3_year_outcome_from_Mainland_Chinese_patients_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1550-7289(16)00094-0 DB - PRIME DP - Unbound Medicine ER -